According to Tilray 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.66257. At the end of 2023 the company had a P/S ratio of 1.98.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.98 | -57.38% |
2022 | 4.65 | -60.06% |
2021 | 11.6 | 192.12% |
2020 | 3.98 | -40.06% |
2019 | 6.65 | -97.66% |
2018 | 284 | 218.04% |
2017 | 89.4 | 77.62% |
2016 | 50.3 | 103.46% |
2015 | 24.7 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.9686 | -63.62% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 93.9 | 3,425.35% | ๐บ๐ธ USA |